SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Bionik Laboratories Corp. – ‘10-Q’ for 12/31/19 – ‘EX-101.SCH’

On:  Friday, 2/14/20, at 8:01am ET   ·   For:  12/31/19   ·   Accession #:  1104659-20-20750   ·   File #:  0-54717

Previous ‘10-Q’:  ‘10-Q’ on 11/14/19 for 9/30/19   ·   Next:  ‘10-Q’ on 8/12/20 for 6/30/20   ·   Latest:  ‘10-Q’ on 2/8/23 for 12/31/22

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/14/20  Bionik Laboratories Corp.         10-Q       12/31/19   65:4.3M                                   Toppan Merrill/FA

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    298K 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     23K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     23K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     20K 
 5: EX-32.2     Certification -- §906 - SOA'02                      HTML     20K 
15: R1          Document And Entity Information                     HTML     49K 
45: R2          Condensed Consolidated Interim Balance Sheets       HTML     92K 
54: R3          Condensed Consolidated Interim Balance Sheets       HTML     46K 
                (Parenthetical)                                                  
30: R4          Condensed Consolidated Interim Statements of        HTML     73K 
                Operations and Comprehensive (Loss)                              
17: R5          Condensed Consolidated Interim Statements of        HTML     85K 
                Changes in Shareholders' Equity                                  
47: R6          Condensed Consolidated Interim Statements of Cash   HTML    101K 
                Flows                                                            
56: R7          Nature of Operations and Going Concern              HTML     35K 
32: R8          Basis of Presentation                               HTML     24K 
13: R9          Significant Accounting Policies                     HTML     36K 
29: R10         Technology and Other Assets                         HTML     74K 
16: R11         Prepaid Expenses and Other Receivables              HTML     39K 
48: R12         Inventories                                         HTML     33K 
57: R13         Equipment                                           HTML     79K 
28: R14         Notes Payable                                       HTML     39K 
14: R15         Related Party Transactions and Balances             HTML     24K 
46: R16         Share Capital                                       HTML     78K 
55: R17         Stock Options                                       HTML     98K 
31: R18         Warrants                                            HTML     63K 
12: R19         Commitments and Contingencies                       HTML     29K 
41: R20         Subsequent Event                                    HTML     21K 
64: R21         Significant Accounting Policies (Policies)          HTML     42K 
27: R22         Technology and Other Assets (Tables)                HTML     73K 
23: R23         Prepaid Expenses and Other Receivables (Tables)     HTML     40K 
40: R24         Inventories (Tables)                                HTML     34K 
63: R25         Equipment (Tables)                                  HTML     78K 
26: R26         Notes Payable (Tables)                              HTML     29K 
22: R27         Share Capital (Tables)                              HTML     75K 
38: R28         Stock Options (Tables)                              HTML     85K 
65: R29         Warrants (Tables)                                   HTML     64K 
52: R30         Nature of Operations and Going Concern (Details)    HTML     52K 
42: R31         Basis of Presentation (Details)                     HTML     24K 
18: R32         Significant Accounting Policies (Details)           HTML     25K 
33: R33         TECHNOLOGY AND OTHER ASSETS - Intangible assets     HTML     47K 
                acquired (Details)                                               
53: R34         TECHNOLOGY AND OTHER ASSETS - Additional            HTML     23K 
                Information (Details)                                            
43: R35         Prepaid Expenses and Other Receivables (Details)    HTML     39K 
19: R36         INVENTORIES- Schedule of Inventories (Details)      HTML     21K 
34: R37         INVENTORIES - Additional Information (Details)      HTML     22K 
51: R38         EQUIPMENT - Schedule of net equipment (Details)     HTML     45K 
44: R39         Equipment (Details)                                 HTML     22K 
61: R40         Notes Payable (Details)                             HTML     69K 
35: R41         Notes Payable - Conversion of Notes Payable         HTML     34K 
                (Details)                                                        
20: R42         Related Party Transactions and Balances (Details)   HTML     41K 
24: R43         SHARE CAPITAL - Common shares issued (Details)      HTML     55K 
62: R44         SHARE CAPITAL - Additional Information (Details)    HTML     56K 
36: R45         STOCK OPTIONS - Summary of stock options            HTML     94K 
                outstanding and exercisable (Details)                            
21: R46         STOCK OPTIONS - Additional Information (Details)    HTML    167K 
25: R47         WARRANTS - Summary of continuity schedule           HTML     39K 
                (Details)                                                        
60: R48         WARRANTS - Summary of common share purchase         HTML     35K 
                warrants outstanding (Details)                                   
37: R49         WARRANTS - Additional Information (Details)         HTML     25K 
50: R50         COMMITMENTS AND CONTINGENCIES - Additional          HTML     52K 
                Information (Details)                                            
58: R51         SUBSEQUENT EVENT - Additional Information           HTML     27K 
                (Details)                                                        
59: XML         IDEA XML File -- Filing Summary                      XML    112K 
49: EXCEL       IDEA Workbook of Financial Reports                  XLSX     66K 
 6: EX-101.INS  XBRL Instance -- bnkl-20191231                       XML   1.53M 
 8: EX-101.CAL  XBRL Calculations -- bnkl-20191231_cal               XML    106K 
 9: EX-101.DEF  XBRL Definitions -- bnkl-20191231_def                XML    393K 
10: EX-101.LAB  XBRL Labels -- bnkl-20191231_lab                     XML    793K 
11: EX-101.PRE  XBRL Presentations -- bnkl-20191231_pre              XML    646K 
 7: EX-101.SCH  XBRL Schema -- bnkl-20191231                         XSD    150K 
39: ZIP         XBRL Zipped Folder -- 0001104659-20-020750-xbrl      Zip    109K 


‘EX-101.SCH’   —   XBRL Schema — bnkl-20191231


This Exhibit is an XBRL XML File.


                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<!-- XBRL document created with Toppan Merrill Bridge 9.5.2.4 -->
<!-- Based on XBRL 2.1 -->
<!-- Created on: 2/13/2020 11:13:47 PM -->
<!-- Modified on: 2/13/2020 11:13:47 PM -->
<schema xmlns:us-gaap="http://fasb.org/us-gaap/2019-01-31" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:us-types="http://fasb.org/us-types/2019-01-31" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:country="http://xbrl.sec.gov/country/2017-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:currency="http://xbrl.sec.gov/currency/2019-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:srt="http://fasb.org/srt/2019-01-31" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:naics="http://xbrl.sec.gov/naics/2017-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:exch="http://xbrl.sec.gov/exch/2019-01-31" xmlns="http://www.w3.org/2001/XMLSchema" targetNamespace="http://www.bionik.com/20191231" elementFormDefault="qualified" xmlns:bnkl="http://www.bionik.com/20191231" xmlns:srt-types="http://fasb.org/srt-types/2019-01-31">
<annotation>
<appinfo>
<link:roleType roleURI="http://www.bionik.com/role/StatementCondensedConsolidatedInterimBalanceSheets" id="StatementCondensedConsolidatedInterimBalanceSheets">
<link:definition> 00100 - Statement - Condensed Consolidated Interim Balance Sheets </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.bionik.com/role/StatementCondensedConsolidatedInterimStatementsOfOperationsAndComprehensiveLoss" id="StatementCondensedConsolidatedInterimStatementsOfOperationsAndComprehensiveLoss">
<link:definition> 00200 - Statement - Condensed Consolidated Interim Statements of Operations and Comprehensive (Loss) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.bionik.com/role/StatementCondensedConsolidatedInterimStatementsOfCashFlows" id="StatementCondensedConsolidatedInterimStatementsOfCashFlows">
<link:definition> 00400 - Statement - Condensed Consolidated Interim Statements of Cash Flows </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.bionik.com/role/DisclosurePrepaidExpensesAndOtherReceivablesDetails" id="DisclosurePrepaidExpensesAndOtherReceivablesDetails">
<link:definition> 40501 - Disclosure - PREPAID EXPENSES AND OTHER RECEIVABLES (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.bionik.com/role/DisclosureEquipmentScheduleOfNetEquipmentDetails" id="DisclosureEquipmentScheduleOfNetEquipmentDetails">
<link:definition> 40701 - Disclosure - EQUIPMENT - Schedule of net equipment (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.bionik.com/role/DocumentDocumentAndEntityInformation" id="DocumentDocumentAndEntityInformation">
<link:definition> 00090 - Document - Document And Entity Information </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.bionik.com/role/StatementCondensedConsolidatedInterimBalanceSheetsParenthetical" id="StatementCondensedConsolidatedInterimBalanceSheetsParenthetical">
<link:definition> 00105 - Statement - Condensed Consolidated Interim Balance Sheets (Parenthetical) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.bionik.com/role/StatementCondensedConsolidatedInterimStatementsOfChangesInShareholdersEquity" id="StatementCondensedConsolidatedInterimStatementsOfChangesInShareholdersEquity">
<link:definition> 00300 - Statement - Condensed Consolidated Interim Statements of Changes in Shareholders' Equity </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.bionik.com/role/DisclosureNotesPayableTables" id="DisclosureNotesPayableTables">
<link:definition> 30803 - Disclosure - NOTES PAYABLE (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.bionik.com/role/DisclosureNatureOfOperationsAndGoingConcernDetails" id="DisclosureNatureOfOperationsAndGoingConcernDetails">
<link:definition> 40101 - Disclosure - NATURE OF OPERATIONS AND GOING CONCERN (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.bionik.com/role/DisclosureBasisOfPresentationDetails" id="DisclosureBasisOfPresentationDetails">
<link:definition> 40201 - Disclosure - BASIS OF PRESENTATION (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.bionik.com/role/DisclosureSignificantAccountingPoliciesDetails" id="DisclosureSignificantAccountingPoliciesDetails">
<link:definition> 40301 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.bionik.com/role/DisclosureTechnologyAndOtherAssetsIntangibleAssetsAcquiredDetails" id="DisclosureTechnologyAndOtherAssetsIntangibleAssetsAcquiredDetails">
<link:definition> 40401 - Disclosure - TECHNOLOGY AND OTHER ASSETS - Intangible assets acquired (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.bionik.com/role/DisclosureTechnologyAndOtherAssetsAdditionalInformationDetails" id="DisclosureTechnologyAndOtherAssetsAdditionalInformationDetails">
<link:definition> 40402 - Disclosure - TECHNOLOGY AND OTHER ASSETS - Additional Information (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.bionik.com/role/DisclosureInventoriesScheduleOfInventoriesDetails" id="DisclosureInventoriesScheduleOfInventoriesDetails">
<link:definition> 40601 - Disclosure - INVENTORIES- Schedule of Inventories (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.bionik.com/role/DisclosureInventoriesAdditionalInformationDetails" id="DisclosureInventoriesAdditionalInformationDetails">
<link:definition> 40602 - Disclosure - INVENTORIES - Additional Information (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.bionik.com/role/DisclosureEquipmentDetails" id="DisclosureEquipmentDetails">
<link:definition> 40702 - Disclosure - EQUIPMENT (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.bionik.com/role/DisclosureNotesPayableDetails" id="DisclosureNotesPayableDetails">
<link:definition> 40801 - Disclosure - NOTES PAYABLE (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.bionik.com/role/DisclosureNotesPayableConversionOfNotesPayableDetails" id="DisclosureNotesPayableConversionOfNotesPayableDetails">
<link:definition> 40802 - Disclosure - NOTES PAYABLE - Conversion of Notes Payable (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.bionik.com/role/DisclosureRelatedPartyTransactionsAndBalancesDetails" id="DisclosureRelatedPartyTransactionsAndBalancesDetails">
<link:definition> 40901 - Disclosure - RELATED PARTY TRANSACTIONS AND BALANCES (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.bionik.com/role/DisclosureShareCapitalCommonSharesIssuedDetails" id="DisclosureShareCapitalCommonSharesIssuedDetails">
<link:definition> 41001 - Disclosure - SHARE CAPITAL - Common shares issued (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.bionik.com/role/DisclosureShareCapitalAdditionalInformationDetails" id="DisclosureShareCapitalAdditionalInformationDetails">
<link:definition> 41002 - Disclosure - SHARE CAPITAL - Additional Information (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.bionik.com/role/DisclosureStockOptionsSummaryOfStockOptionsOutstandingAndExercisableDetails" id="DisclosureStockOptionsSummaryOfStockOptionsOutstandingAndExercisableDetails">
<link:definition> 41101 - Disclosure - STOCK OPTIONS - Summary of stock options outstanding and exercisable (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.bionik.com/role/DisclosureStockOptionsAdditionalInformationDetails" id="DisclosureStockOptionsAdditionalInformationDetails">
<link:definition> 41102 - Disclosure - STOCK OPTIONS - Additional Information (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.bionik.com/role/DisclosureWarrantsSummaryOfContinuityScheduleDetails" id="DisclosureWarrantsSummaryOfContinuityScheduleDetails">
<link:definition> 41201 - Disclosure - WARRANTS - Summary of continuity schedule (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.bionik.com/role/DisclosureWarrantsSummaryOfCommonSharePurchaseWarrantsOutstandingDetails" id="DisclosureWarrantsSummaryOfCommonSharePurchaseWarrantsOutstandingDetails">
<link:definition> 41202 - Disclosure - WARRANTS - Summary of common share purchase warrants outstanding (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.bionik.com/role/DisclosureWarrantsAdditionalInformationDetails" id="DisclosureWarrantsAdditionalInformationDetails">
<link:definition> 41203 - Disclosure - WARRANTS - Additional Information (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.bionik.com/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" id="DisclosureCommitmentsAndContingenciesAdditionalInformationDetails">
<link:definition> 41301 - Disclosure - COMMITMENTS AND CONTINGENCIES - Additional Information (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.bionik.com/role/DisclosureSubsequentEventAdditionalInformationDetails" id="DisclosureSubsequentEventAdditionalInformationDetails">
<link:definition> 41401 - Disclosure - SUBSEQUENT EVENT - Additional Information (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.bionik.com/role/DisclosureNatureOfOperationsAndGoingConcern" id="DisclosureNatureOfOperationsAndGoingConcern">
<link:definition> 10101 - Disclosure - NATURE OF OPERATIONS AND GOING CONCERN </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.bionik.com/role/DisclosureBasisOfPresentation" id="DisclosureBasisOfPresentation">
<link:definition> 10201 - Disclosure - BASIS OF PRESENTATION </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.bionik.com/role/DisclosureSignificantAccountingPolicies" id="DisclosureSignificantAccountingPolicies">
<link:definition> 10301 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.bionik.com/role/DisclosureTechnologyAndOtherAssets" id="DisclosureTechnologyAndOtherAssets">
<link:definition> 10401 - Disclosure - TECHNOLOGY AND OTHER ASSETS </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.bionik.com/role/DisclosurePrepaidExpensesAndOtherReceivables" id="DisclosurePrepaidExpensesAndOtherReceivables">
<link:definition> 10501 - Disclosure - PREPAID EXPENSES AND OTHER RECEIVABLES </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.bionik.com/role/DisclosureInventories" id="DisclosureInventories">
<link:definition> 10601 - Disclosure - INVENTORIES </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.bionik.com/role/DisclosureEquipment" id="DisclosureEquipment">
<link:definition> 10701 - Disclosure - EQUIPMENT </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.bionik.com/role/DisclosureNotesPayable" id="DisclosureNotesPayable">
<link:definition> 10801 - Disclosure - NOTES PAYABLE </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.bionik.com/role/DisclosureRelatedPartyTransactionsAndBalances" id="DisclosureRelatedPartyTransactionsAndBalances">
<link:definition> 10901 - Disclosure - RELATED PARTY TRANSACTIONS AND BALANCES </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.bionik.com/role/DisclosureShareCapital" id="DisclosureShareCapital">
<link:definition> 11001 - Disclosure - SHARE CAPITAL </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.bionik.com/role/DisclosureStockOptions" id="DisclosureStockOptions">
<link:definition> 11101 - Disclosure - STOCK OPTIONS </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.bionik.com/role/DisclosureWarrants" id="DisclosureWarrants">
<link:definition> 11201 - Disclosure - WARRANTS </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.bionik.com/role/DisclosureCommitmentsAndContingencies" id="DisclosureCommitmentsAndContingencies">
<link:definition> 11301 - Disclosure - COMMITMENTS AND CONTINGENCIES </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.bionik.com/role/DisclosureSubsequentEvent" id="DisclosureSubsequentEvent">
<link:definition> 11401 - Disclosure - SUBSEQUENT EVENT </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.bionik.com/role/DisclosureSignificantAccountingPoliciesPolicies" id="DisclosureSignificantAccountingPoliciesPolicies">
<link:definition> 20302 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.bionik.com/role/DisclosureTechnologyAndOtherAssetsTables" id="DisclosureTechnologyAndOtherAssetsTables">
<link:definition> 30403 - Disclosure - TECHNOLOGY AND OTHER ASSETS (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.bionik.com/role/DisclosurePrepaidExpensesAndOtherReceivablesTables" id="DisclosurePrepaidExpensesAndOtherReceivablesTables">
<link:definition> 30503 - Disclosure - PREPAID EXPENSES AND OTHER RECEIVABLES (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.bionik.com/role/DisclosureInventoriesTables" id="DisclosureInventoriesTables">
<link:definition> 30603 - Disclosure - INVENTORIES (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.bionik.com/role/DisclosureEquipmentTables" id="DisclosureEquipmentTables">
<link:definition> 30703 - Disclosure - EQUIPMENT (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.bionik.com/role/DisclosureShareCapitalTables" id="DisclosureShareCapitalTables">
<link:definition> 31003 - Disclosure - SHARE CAPITAL (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.bionik.com/role/DisclosureStockOptionsTables" id="DisclosureStockOptionsTables">
<link:definition> 31103 - Disclosure - STOCK OPTIONS (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.bionik.com/role/DisclosureWarrantsTables" id="DisclosureWarrantsTables">
<link:definition> 31203 - Disclosure - WARRANTS (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:linkbaseRef xlink:type="simple" xlink:href="bnkl-20191231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
<link:linkbaseRef xlink:type="simple" xlink:href="bnkl-20191231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
<link:linkbaseRef xlink:type="simple" xlink:href="bnkl-20191231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
<link:linkbaseRef xlink:type="simple" xlink:href="bnkl-20191231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
</appinfo>
</annotation>
<import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
<import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
<import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
<import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>
<import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd"/>
<import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
<import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
<import namespace="http://fasb.org/us-roles/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd"/>
<import namespace="http://fasb.org/us-gaap/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd"/>
<import namespace="http://fasb.org/srt/2019-01-31" schemaLocation="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd"/>
<element name="CommonStockOtherSharesIssued" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="bnkl_CommonStockOtherSharesIssued" substitutionGroup="xbrli:item"/>
<element name="SaleRevenueNet" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="bnkl_SaleRevenueNet" substitutionGroup="xbrli:item" xbrli:balance="credit"/>
<element id="bnkl_GainOnMarkToMarketReevaluation" name="GainOnMarkToMarketReevaluation" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xbrli:balance="credit"/>
<element id="bnkl_AdjustmentToAdditionalPaidInCapitalWarrantDownFeature" name="AdjustmentToAdditionalPaidInCapitalWarrantDownFeature" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xbrli:balance="credit"/>
<element id="bnkl_AdjustmentsToAdditionalPaidInCapitalStockOptionAndWarrantReclassification" name="AdjustmentsToAdditionalPaidInCapitalStockOptionAndWarrantReclassification" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xbrli:balance="credit"/>
<element id="bnkl_AdjustmentsDueToShareConsolidationRoundUp" name="AdjustmentsDueToShareConsolidationRoundUp" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xbrli:balance="debit"/>
<element id="bnkl_AdjustmentsDueToShareConsolidationRoundUpShares" name="AdjustmentsDueToShareConsolidationRoundUpShares" nillable="true" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration"/>
<element id="bnkl_LossOnMarkToMarketReevaluation" name="LossOnMarkToMarketReevaluation" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xbrli:balance="debit"/>
<element name="TechnologyAndOtherIntangibleAssetsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="bnkl_TechnologyAndOtherIntangibleAssetsAbstract" substitutionGroup="xbrli:item"/>
<element id="bnkl_PrepaidExpenseAndOtherReceivablesTextBlock" name="PrepaidExpenseAndOtherReceivablesTextBlock" nillable="true" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration"/>
<element id="bnkl_ShareholdersEquityAndShareBasedPaymentsStockWarrantTextBlock" name="ShareholdersEquityAndShareBasedPaymentsStockWarrantTextBlock" nillable="true" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration"/>
<element name="RecentlyAdoptedAccountingPronouncementsPolicyTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="bnkl_RecentlyAdoptedAccountingPronouncementsPolicyTextBlock" substitutionGroup="xbrli:item"/>
<element id="bnkl_ConsolidatedFinancialStatementsPolicyTextBlock" name="ConsolidatedFinancialStatementsPolicyTextBlock" nillable="true" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration"/>
<element id="bnkl_ScheduleOfShareBasedCompensationStockPurchaseWarrantsActivityTableTextBlock" name="ScheduleOfShareBasedCompensationStockPurchaseWarrantsActivityTableTextBlock" nillable="true" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration"/>
<element id="bnkl_ScheduleOfCommonSharePurchaseWarrantsOutstandingTableTextBlock" name="ScheduleOfCommonSharePurchaseWarrantsOutstandingTableTextBlock" nillable="true" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration"/>
<element name="ShareExchangeAgreementMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="bnkl_ShareExchangeAgreementMember" substitutionGroup="xbrli:item"/>
<element name="InteractiveMotionTechnologiesIncMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="bnkl_InteractiveMotionTechnologiesIncMember" substitutionGroup="xbrli:item"/>
<element name="WorkingCapitalSurplusDeficit" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="bnkl_WorkingCapitalSurplusDeficit" substitutionGroup="xbrli:item" xbrli:balance="credit"/>
<element name="PatentsAndExclusiveLicenseAgreementMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="bnkl_PatentsAndExclusiveLicenseAgreementMember" substitutionGroup="xbrli:item"/>
<element name="AssembledWorkforceMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="bnkl_AssembledWorkforceMember" substitutionGroup="xbrli:item"/>
<element name="PrepaidExpenseAndOtherReceivablesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="bnkl_PrepaidExpenseAndOtherReceivablesTable" substitutionGroup="xbrldt:hypercubeItem"/>
<element name="PrepaidExpenseAndOtherReceivablesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="bnkl_PrepaidExpenseAndOtherReceivablesLineItems" substitutionGroup="xbrli:item"/>
<element name="PrepaidExpensesAndSundryReceivables" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="bnkl_PrepaidExpensesAndSundryReceivables" substitutionGroup="xbrli:item" xbrli:balance="debit"/>
<element name="PrepaidInventory" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="bnkl_PrepaidInventory" substitutionGroup="xbrli:item" xbrli:balance="debit"/>
<element name="InventoryCostMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="bnkl_InventoryCostMember" substitutionGroup="xbrli:item"/>
<element name="EquipmentTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="bnkl_EquipmentTable" substitutionGroup="xbrldt:hypercubeItem"/>
<element name="DemonstrationEquipmentMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="bnkl_DemonstrationEquipmentMember" substitutionGroup="xbrli:item"/>
<element name="ManufacturingEquipmentMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="bnkl_ManufacturingEquipmentMember" substitutionGroup="xbrli:item"/>
<element name="EquipmentLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="bnkl_EquipmentLineItems" substitutionGroup="xbrli:item"/>
<element name="ConvertibleLoansPayableMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="bnkl_ConvertibleLoansPayableMember" substitutionGroup="xbrli:item"/>
<element name="ConvertibleDebtOneMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="bnkl_ConvertibleDebtOneMember" substitutionGroup="xbrli:item"/>
<element name="ConvertibleDebtTwoMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="bnkl_ConvertibleDebtTwoMember" substitutionGroup="xbrli:item"/>
<element name="ChiefTechnologyOfficerMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="bnkl_ChiefTechnologyOfficerMember" substitutionGroup="xbrli:item"/>
<element name="CommonSharesAndExchangeableSharesMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="bnkl_CommonSharesAndExchangeableSharesMember" substitutionGroup="xbrli:item"/>
<element name="StockIssuedDuringPeriodSharesConversionOfLoans" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="bnkl_StockIssuedDuringPeriodSharesConversionOfLoans" substitutionGroup="xbrli:item"/>
<element id="bnkl_StockIssuedDuringPeriodValueConversionOfLoans" name="StockIssuedDuringPeriodValueConversionOfLoans" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xbrli:balance="credit"/>
<element name="StockOptionOneMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="bnkl_StockOptionOneMember" substitutionGroup="xbrli:item"/>
<element name="StockOptionTwoMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="bnkl_StockOptionTwoMember" substitutionGroup="xbrli:item"/>
<element name="StockOptionThreeMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="bnkl_StockOptionThreeMember" substitutionGroup="xbrli:item"/>
<element name="StockOptionFourMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="bnkl_StockOptionFourMember" substitutionGroup="xbrli:item"/>
<element name="StockOptionFiveMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="bnkl_StockOptionFiveMember" substitutionGroup="xbrli:item"/>
<element name="StockOptionSixMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="bnkl_StockOptionSixMember" substitutionGroup="xbrli:item"/>
<element name="StockOptionSevenMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="bnkl_StockOptionSevenMember" substitutionGroup="xbrli:item"/>
<element name="StockOptionEightMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="bnkl_StockOptionEightMember" substitutionGroup="xbrli:item"/>
<element name="StockOptionNineMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="bnkl_StockOptionNineMember" substitutionGroup="xbrli:item"/>
<element name="StockOptionTenMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="bnkl_StockOptionTenMember" substitutionGroup="xbrli:item"/>
<element name="StockOptionElevenMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="bnkl_StockOptionElevenMember" substitutionGroup="xbrli:item"/>
<element name="StockOptionTwelveMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="bnkl_StockOptionTwelveMember" substitutionGroup="xbrli:item"/>
<element name="StockOptionThirteenMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="bnkl_StockOptionThirteenMember" substitutionGroup="xbrli:item"/>
<element name="StockOptionFourteenMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="bnkl_StockOptionFourteenMember" substitutionGroup="xbrli:item"/>
<element name="StockOptionFifteenMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="bnkl_StockOptionFifteenMember" substitutionGroup="xbrli:item"/>
<element name="StockOptionSixteenMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="bnkl_StockOptionSixteenMember" substitutionGroup="xbrli:item"/>
<element name="StockOptionSeventeenMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="bnkl_StockOptionSeventeenMember" substitutionGroup="xbrli:item"/>
<element name="StockOptionEighteenMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="bnkl_StockOptionEighteenMember" substitutionGroup="xbrli:item"/>
<element name="StockOptionNineteenMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="bnkl_StockOptionNineteenMember" substitutionGroup="xbrli:item"/>
<element name="StockOptionTwentyMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="bnkl_StockOptionTwentyMember" substitutionGroup="xbrli:item"/>
<element name="StockOptionTwentyOneMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="bnkl_StockOptionTwentyOneMember" substitutionGroup="xbrli:item"/>
<element name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionExpirationDate" type="xbrli:dateItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="bnkl_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionExpirationDate" substitutionGroup="xbrli:item"/>
<element name="NewExecutiveOfficerMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="bnkl_NewExecutiveOfficerMember" substitutionGroup="xbrli:item"/>
<element name="EmployeesOfBionikIncMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="bnkl_EmployeesOfBionikIncMember" substitutionGroup="xbrli:item"/>
<element name="EmployeesMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="bnkl_EmployeesMember" substitutionGroup="xbrli:item"/>
<element name="EmployeeTwoMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="bnkl_EmployeeTwoMember" substitutionGroup="xbrli:item"/>
<element name="ExecutiveEmployeeAndConsultantMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="bnkl_ExecutiveEmployeeAndConsultantMember" substitutionGroup="xbrli:item"/>
<element name="EmployeesVestEquallyOnJanuary242019Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="bnkl_EmployeesVestEquallyOnJanuary242019Member" substitutionGroup="xbrli:item"/>
<element name="EmployeesVestEquallyOnJanuary242020Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="bnkl_EmployeesVestEquallyOnJanuary242020Member" substitutionGroup="xbrli:item"/>
<element name="EmployeesVestEquallyOnJanuary242021Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="bnkl_EmployeesVestEquallyOnJanuary242021Member" substitutionGroup="xbrli:item"/>
<element name="Warrants1Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="bnkl_Warrants1Member" substitutionGroup="xbrli:item"/>
<element name="Warrants2Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="bnkl_Warrants2Member" substitutionGroup="xbrli:item"/>
<element name="WarrantThreeMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="bnkl_WarrantThreeMember" substitutionGroup="xbrli:item"/>
<element name="WarrantFourMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="bnkl_WarrantFourMember" substitutionGroup="xbrli:item"/>
<element name="WarrantOneMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="bnkl_WarrantOneMember" substitutionGroup="xbrli:item"/>
<element name="WarrantTwoMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="bnkl_WarrantTwoMember" substitutionGroup="xbrli:item"/>
<element name="Warrant3Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="bnkl_Warrant3Member" substitutionGroup="xbrli:item"/>
<element name="ClassOfWarrantOrRightExpiryDate" type="xbrli:dateItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="bnkl_ClassOfWarrantOrRightExpiryDate" substitutionGroup="xbrli:item"/>
<element name="StockTransferredToLenders" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="bnkl_StockTransferredToLenders" substitutionGroup="xbrli:item"/>
<element name="StockToBeReimbursedToOfficers" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="bnkl_StockToBeReimbursedToOfficers" substitutionGroup="xbrli:item"/>
<element id="bnkl_ExchangeableSharesMember" name="ExchangeableSharesMember" nillable="true" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration"/>
<element id="bnkl_SpecialVotingPreferredStockMember" name="SpecialVotingPreferredStockMember" nillable="true" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration"/>
<element id="bnkl_ContributionsRequiredFromPartnerWithinThirtyDaysOfJointVentureFormation" name="ContributionsRequiredFromPartnerWithinThirtyDaysOfJointVentureFormation" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xbrli:balance="debit"/>
<element id="bnkl_ContributionRequiredFromPartnerTwelveMonthsAfterJointVentureFormation" name="ContributionRequiredFromPartnerTwelveMonthsAfterJointVentureFormation" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xbrli:balance="debit"/>
<element id="bnkl_ContributionRequiredFromPartnerSixtyMonthsAfterJointVentureFormation" name="ContributionRequiredFromPartnerSixtyMonthsAfterJointVentureFormation" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xbrli:balance="debit"/>
<element id="bnkl_LoanReceivedAndRepaid" name="LoanReceivedAndRepaid" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xbrli:balance="debit"/>
<element id="bnkl_FormerChiefTechnologyOfficerAndNewChiefTechnologyOfficerMember" name="FormerChiefTechnologyOfficerAndNewChiefTechnologyOfficerMember" nillable="true" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration"/>
<element id="bnkl_ShareExchangeRatio" name="ShareExchangeRatio" nillable="true" type="xbrli:pureItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration"/>
<element id="bnkl_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumPercentageSharesReserved" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumPercentageSharesReserved" nillable="true" type="num:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant"/>
<element id="bnkl_ChinaBasedJointVentureMember" name="ChinaBasedJointVentureMember" nillable="true" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration"/>
<element id="bnkl_EuropeanPromissoryNotesTrancheThreeMember" name="EuropeanPromissoryNotesTrancheThreeMember" nillable="true" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration"/>
<element id="bnkl_PercentageOfRoyaltyOnSales" name="PercentageOfRoyaltyOnSales" nillable="true" type="num:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration"/>
<element id="bnkl_StockIssuedDuringPeriodSharesUponCashlessExerciseOfWarrants" name="StockIssuedDuringPeriodSharesUponCashlessExerciseOfWarrants" nillable="true" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration"/>
<element id="bnkl_StockIssuedDuringPeriodValueUponCashlessExerciseOfWarrants" name="StockIssuedDuringPeriodValueUponCashlessExerciseOfWarrants" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xbrli:balance="credit"/>
<element id="bnkl_ChiefCommercialOfficerMember" name="ChiefCommercialOfficerMember" nillable="true" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration"/>
<element id="bnkl_InvestorsMember" name="InvestorsMember" nillable="true" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration"/>
<element id="bnkl_TermLoanMember" name="TermLoanMember" nillable="true" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration"/>
<element id="bnkl_DirectorAndEmployeesMember" name="DirectorAndEmployeesMember" nillable="true" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration"/>
<element id="bnkl_BasisOfPresentationAbstract" name="BasisOfPresentationAbstract" nillable="true" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration"/>
<element id="bnkl_AdjustmentsToAdditionalPaidInCapitalFairValueOfAntiDilutionFeature" name="AdjustmentsToAdditionalPaidInCapitalFairValueOfAntiDilutionFeature" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xbrli:balance="credit"/>
<element id="bnkl_ConvertibleLoansPayableWithConversionPriceOneMember" name="ConvertibleLoansPayableWithConversionPriceOneMember" nillable="true" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration"/>
<element id="bnkl_ConvertibleLoansPayableWithConversionPriceTwoMember" name="ConvertibleLoansPayableWithConversionPriceTwoMember" nillable="true" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration"/>
<element id="bnkl_ConvertibleLoansPayableTwoMember" name="ConvertibleLoansPayableTwoMember" nillable="true" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration"/>
<element id="bnkl_ConvertibleLoansPayableWithConversionPriceThreeMember" name="ConvertibleLoansPayableWithConversionPriceThreeMember" nillable="true" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration"/>
<element id="bnkl_ConvertibleLoansPayableWithConversionPriceFourMember" name="ConvertibleLoansPayableWithConversionPriceFourMember" nillable="true" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration"/>
<element id="bnkl_LineOfCreditFacilityMaximumBorrowingCapacityAtDiscretionOfCompany" name="LineOfCreditFacilityMaximumBorrowingCapacityAtDiscretionOfCompany" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" xbrli:balance="credit"/>
<element id="bnkl_ShareBasedPaymentArrangementEmployeesAndConsultantsMember" name="ShareBasedPaymentArrangementEmployeesAndConsultantsMember" nillable="true" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration"/>
<element id="bnkl_ShareBasedCompensationArrangementByShareBasedPaymentsAwardNonOptionsExercisedWeightedAverageExercisePrice" name="ShareBasedCompensationArrangementByShareBasedPaymentsAwardNonOptionsExercisedWeightedAverageExercisePrice" nillable="true" type="num:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant"/>
<element id="bnkl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWeightedAverageExercisePriceIssued" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWeightedAverageExercisePriceIssued" nillable="true" type="num:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration"/>
<element id="bnkl_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExpiredWeightedAverageExercisePrice" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExpiredWeightedAverageExercisePrice" nillable="true" type="num:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration"/>
<element id="bnkl_RepaymentsOfDemandNotesPrincipal" name="RepaymentsOfDemandNotesPrincipal" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xbrli:balance="credit"/>
<element id="bnkl_RepaymentsOfDemandNotesInterest" name="RepaymentsOfDemandNotesInterest" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xbrli:balance="credit"/>
<element id="bnkl_StockIssuedDuringPeriodSharesExchangeableSharesExercised" name="StockIssuedDuringPeriodSharesExchangeableSharesExercised" nillable="true" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration"/>
<element id="bnkl_LineOfCreditFacilityMaximumBorrowingCapacityOfLoan" name="LineOfCreditFacilityMaximumBorrowingCapacityOfLoan" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xbrli:balance="credit"/>
<element id="bnkl_PurchaseObligationTerm" name="PurchaseObligationTerm" nillable="true" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration"/>
</schema>

Top
Filing Submission 0001104659-20-020750   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sun., Apr. 28, 12:36:24.1pm ET